Table 4.
Absolute Differences for Each SDOCT Modality from Spectralis HR
| Mean ± SD | ||||
|---|---|---|---|---|
| SDOCT Variable | Spectralis HR vs. Spectralis HS | Spectralis HR vs. Cirrus Cube | Spectralis HR vs. Cirrus HD 5-Line | Spectralis HR vs. AngioVue OP |
| DRIL extent (µm) | 60.0 ± 55.0 | 98.2 ± 88.6 | 130.8 ± 112.1 | 51.1 ± 71.6 |
| By blurriness | 38.2 ± 38.6 | 66.0 ± 80.1 | 66.9 ± 90.1 | 3.7 ± 9.1 |
| By cysts | 43.9 ± 41.5 | 57.8 ± 47.1 | 67.8 ± 67.2 | 39.1 ± 75.3 |
| By hyperreflective foci | 36.5 ± 36.8 | 27.9 ± 34.6 | 35.1 ± 41.5 | 17.5 ± 14.5 |
| Cyst area (µm2) | 4013.9 ± 6766.3 | 4936.8 ± 6368.5 | 5132.2 ± 5139.0 | 2701.6 ± 4075.1 |
| COST visibility extent (µm) | 86.7 ± 103.6 | 124.2 ±128.9 | 183.2 ± 147.6 | 138.4 ± 132.3 |
| SRF horizontal extent (µm) | 20.8 ± 88.8 | 18.9 ± 88.4 | 15.6 ± 49.4 | 1.9 ± 10.1 |